MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NRXPW has $14,996K in assets. $40,751K in debts. $7,184K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
29.43%
Cash Ratio
17.70%
Debt to Asset Ratio
271.75%
Assets Breakdown
    • Cash and cash equivalents
    • Subscription receivable
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
7,184 2,910
Accounts receivable, net
239 -
Prepaid expense and other current assets
1,437 1,680
Subscription receivable
3,087 -
Total current assets
11,947 4,590
Other assets
243 248
Ppe
93 -
Nrx Segment
23 -
Dura Segment
1 -
Less accumulated depreciation
24 -
Furniture and equipment, net
69 -
Right-of-use assets, net-Nonrelated Party
107 -
Right-of-use assets, net-Related Party
243 -
Intangible assets, net
1,777 -
Goodwill
610 -
Total assets
14,996 4,838
Accounts payable
4,257 3,630
Accrued and other current liabilities
9,875 9,974
Accrued clinical site costs
351 351
Convertible note payable and accrued interest, current
9,909 9,854
Insurance loan payable
152 378
Warrant liabilities
15,860 16,266
Lease liability, short term-Nonrelated Party
87 -
Lease liability, short term-Related Party
102 -
Total current liabilities
40,593 40,453
Convertible note payable and accrued interest, long term
0 0
Lease liability, noncurrent-Nonrelated Party
15 -
Lease liability, noncurrent-Related Party
143 -
Total liabilities
40,751 40,453
Preferred stock-Nondesignated Preferred Stock
0 0
Preferred stock-Series AConvertible Preferred Stock
0 0
Common stock, 0.001 par value, 500,000,000 shares authorized 27,682,530 and 14,591,505 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
28 19
Additional paid-in capital
281,473 265,732
Accumulated deficit
-307,256 -301,366
Total stockholders deficit
-25,755 -35,615
Total liabilities and stockholders' deficit
14,996 4,838
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Ppe$93K Subscription receivable$3,087K Prepaid expense andother current assets$1,437K Accounts receivable, net$239K Cash and cashequivalents$7,184K Goodwill$610K Intangible assets, net$1,777K Right-of-use assets,net-Related Party$243K Right-of-use assets,net-Nonrelated Party$107K Furniture and equipment,net$69K Other assets$243K Total current assets$11,947K Less accumulateddepreciation$24K Total assets$14,996K Accumulated deficit-$307,256K Dura Segment$1K Nrx Segment$23K Total liabilities andstockholders' deficit$14,996K Total stockholdersdeficit-$25,755K Additional paid-in capital$281,473K Common stock, 0.001 parvalue, 500,000,000...$28K Total liabilities$40,751K Lease liability,noncurrent-Related Party$143K Lease liability,noncurrent-Nonrelated Party$15K Total currentliabilities$40,593K Lease liability,short term-Related...$102K Lease liability,short...$87K Warrant liabilities$15,860K Insurance loan payable$152K Convertible note payable andaccrued interest,...$9,909K Accrued clinical sitecosts$351K Accrued and othercurrent liabilities$9,875K Accounts payable$4,257K

NRX Pharmaceuticals, Inc. (NRXPW)

NRX Pharmaceuticals, Inc. (NRXPW)